04/01/2024 5:04 AM | CymaBay Therapeutics (Filer)
| Form 15-12G | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024 11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/22/2024 3:54 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
|
03/22/2024 3:54 PM | CymaBay Therapeutics (Issuer) WIGGANS THOMAS G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:55 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:55 PM | CymaBay Therapeutics (Issuer) Wills Robert James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:55 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024 3:56 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024 3:58 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024 3:59 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:02 PM | CymaBay Therapeutics (Issuer) Dickinson Klara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:03 PM | CymaBay Therapeutics (Issuer) Shantharam Harish (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:03 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:05 PM | CymaBay Therapeutics (Issuer) Lefebvre Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:06 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:09 PM | CymaBay Therapeutics (Issuer) Loewy Caroline M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:28 PM | CymaBay Therapeutics (Filer)
| Form POSASR | |
03/22/2024 3:31 PM | CymaBay Therapeutics (Filer)
| Form POSASR | |
03/22/2024 9:53 AM | CymaBay Therapeutics (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
03/22/2024 8:22 AM | CymaBay Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 6:50 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/22/2024 6:56 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/20/2024 3:24 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/20/2024 3:12 PM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/15/2024 3:11 PM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/15/2024 3:12 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/11/2024 8:14 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/11/2024 7:34 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/07/2024 3:35 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
02/28/2024 3:31 PM | CymaBay Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/23/2024 5:25 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9 | |
02/23/2024 5:09 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T | |
02/16/2024 4:14 PM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/15/2024 3:15 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 5:43 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:46 PM | CymaBay Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 11:50 AM | CymaBay Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad) A strange new era for mankind is upon us...
And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day.
Elon believes A.I. is advancing so fast... This strange new device to protect us against that A.I. threat... |
02/14/2024 8:09 AM | Avoro Capital Advisors LLC (Filed by) CymaBay Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 4:29 PM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/12/2024 7:42 AM | CymaBay Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:45 AM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/12/2024 7:39 AM | CymaBay Therapeutics (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-C | |
02/06/2024 4:38 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 4:00 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 5:33 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 4:59 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024 5:10 PM | CymaBay Therapeutics (Issuer) EMSTER KURT VON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:16 PM | CymaBay Therapeutics (Issuer) Lefebvre Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:17 PM | CymaBay Therapeutics (Issuer) Loewy Caroline M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:18 PM | CymaBay Therapeutics (Issuer) WIGGANS THOMAS G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:19 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:20 PM | CymaBay Therapeutics (Issuer) Wills Robert James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:27 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:28 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:29 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:30 PM | CymaBay Therapeutics (Issuer) Dickinson Klara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2024 5:33 PM | CymaBay Therapeutics (Issuer) Shantharam Harish (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 5:59 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 3:33 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 6:15 PM | CymaBay Therapeutics (Subject) McWherter Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:44 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:39 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024 3:54 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 6:07 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:07 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:23 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 3:24 PM | CymaBay Therapeutics (Subject) Quinlan Paul T (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 7:35 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:11 PM | CymaBay Therapeutics (Subject) Dorling Janet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024 3:50 PM | CymaBay Therapeutics (Subject) STUART LEWIS J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 7:04 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:35 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:38 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:01 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:03 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:39 PM | CymaBay Therapeutics (Subject) Shah Sujal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023 4:57 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 4:57 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 4:58 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 4:56 PM | CymaBay Therapeutics (Issuer) Dorling Janet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 5:00 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 8:08 AM | CymaBay Therapeutics (Subject) Dorling Janet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2023 5:21 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 5:22 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 5:22 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2023 3:16 PM | CymaBay Therapeutics (Subject) Quinlan Paul T (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2023 3:16 PM | CymaBay Therapeutics (Subject) Menold Daniel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Trump’s last act as President (Ad) You’ve probably never heard of Executive Order #13972.
Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. |
10/10/2023 4:04 PM | CymaBay Therapeutics (Issuer) Shah Sujal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 7:55 AM | CymaBay Therapeutics (Subject) Shah Sujal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023 4:54 PM | CymaBay Therapeutics (Issuer) EMSTER KURT VON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 3:54 PM | CymaBay Therapeutics (Subject) EMSTER KURT VON (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023 3:30 PM | CymaBay Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
09/19/2023 4:23 PM | CymaBay Therapeutics (Issuer) Quinlan Paul T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 4:25 PM | CymaBay Therapeutics (Issuer) Menold Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 4:27 PM | CymaBay Therapeutics (Issuer) McWherter Charles (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:04 PM | CymaBay Therapeutics (Subject) McWherter Charles (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |